Rallybio
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Rallybio's balance sheet done over the years? Its assets were worth $115,620,000 last year, which is less than in the previous period. 8% of Rallybio’s total assets is currently financed by debt. Its liabilities reached the amount of $9,436,000, which means an decrease by -15% compared compared to last year.

Debt to Assets

Rallybio Corporation (NASDAQ:RLYB): Debt to assets
2019 21607000 41.88M 193.86%
2020 141858000 187.88M 132.44%
2021 182185000 6.58M 3.61%
2022 180435000 11.11M 6.16%
2023 115620000 9.43M 8.16%

RLYB Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
24.49M56.95M175.33M140.23M19.45M
Short term investments
85.43M112.03M000
Net receivables
00000
Inventory
00000
Other current assets
4.86M1.05M5.53M1.02M1.46M
Total current assets
114.78M179.49M180.86M141.26M20.92M
Non-current assets:
Property, Plant and Equipment
592K909K511K287K199K
Goodwill
00000
Intangible assets
00000
Long term investments
239K30K805K310K488K
Other non-current assets
00000
Total non-current assets
831K939K1.31M597K687K
Total assets
115.62M180.43M182.18M141.85M21.60M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
438K181K000
Total current liabilities
9.26M10.74M6.55M5.84M3.80M
Non-current liabilities:
Long term debt
173K374K000
Deferred tax
00000
Other non-current liabilities
0032K182.03M38.08M
Total non-current liabilities
173K374K32K182.03M38.08M
Total liabilities
9.43M11.11M6.58M187.88M41.88M
Data sourceData sourceData source